Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$52,500.00
May 1, 2012
An evaluation of the management of hypertension by pharmacists with prescribing authorization, and the clinical effectiveness and feasibility of remunerating pharmacists for providing clinical hypertension care to improve cardiovascular outcomes
$75,000.00
May 1, 2012
2012 Symposium on Sensible Guidelines for the Conduct of Clinical Trials
$70,000.00
May 1, 2012
Low back pain in Quebec's Multidisciplinary pain Treatment Clinics: how good and how much?
$105,000.00
May 1, 2012
Influencing Trajectories of Care for People with Dementia: Understanding Clinical and Non-Clinical Service Variations in Dementia Management
$50,000.00
Apr 27, 2012
200631
200631
Hire consultant with clinical expertise for business planning
$588,895.00
Apr 1, 2012
PP2a protein serine/threonine phosphatase mutations in cancer: functional consequences and clinical relevance
$319,820.00
Apr 1, 2012
Signal, Safety, and Success: An Analysis of Risk, Benefit, and Translation after Detection of Clinical Activity in Drug Development
$472,514.00
Apr 1, 2012
The Role of Sirtuin1 in Diabetic Nephropathy: Experimental and Clinical Studies
$143,425.00
Apr 1, 2012
The Impact of Drug Exposure Misclassification on Study Estimates of Clinical Outcomes in Administrative Drug Databases
$804,467.00
Apr 1, 2012
Translational strategies for the clinical transplantation of neonatal porcine islets.